Country: United States of America (the),France,Canada,China,Korea (the Republic of),Italy,Argentina,Australia,Portugal,Mexico,Netherlands (Kingdom of the),Belgium,Japan,Sweden,Spain

A study to assess the effectiveness and safety of 2 dosage regimens of oral fidrisertib (IPN60130) for the treatment of Fibrodysplasia Ossificans Progressiva (FOP)